Spyre Therapeutics, Inc.SYRENASDAQ
Loading
Total Costs & Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+51.0%
5Y CAGR+29.8%
Year-over-Year Change
Total of all costs and expenses
3Y CAGR
+51.0%/yr
vs +15.3%/yr prior
5Y CAGR
+29.8%/yr
Recent acceleration
Acceleration
+35.8pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
3.7x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $300.06M | +43.9% |
| 2024 | $208.57M | -14.2% |
| 2023 | $243.19M | +179.2% |
| 2022 | $87.11M | +3.2% |
| 2021 | $84.39M | +3.6% |
| 2020 | $81.48M | +1.4% |
| 2019 | $80.33M | +62.8% |
| 2018 | $49.35M | +50.1% |
| 2017 | $32.88M | +23.9% |
| 2016 | $26.53M | - |